Ozempic starts at 0.25 mg once weekly for four weeks, then moves to 0.5 mg, and can step up to 1 mg and a maximum of 2 mg if the prescriber decides more is needed for blood sugar control. That is the whole schedule on the label. The 0.25 mg opening dose is not a treatment dose at all; it is there to let your body get used to the drug. There is no single correct number for everyone, which is the part most people miss.
What does the label actually say?
Ozempic is approved for type 2 diabetes, and the prescribing information sets out a paced titration rather than a fixed prescription. The starting 0.25 mg dose runs for four weeks, then 0.5 mg for at least four weeks, then an optional increase to 1 mg, and a further optional increase to 2 mg. Each step is meant to be held long enough to judge tolerance and effect. You can read the exact increments in the OZEMPIC prescribing information, and it is worth checking against whatever a pen or a website tells you.
The point of the slow ramp is gut tolerance. Semaglibe acts on GLP-1 receptors that slow stomach emptying, and jumping straight to a high dose reliably produces more nausea, not more benefit. The mechanism behind that is described in a 2024 review of GLP-1 and dual GIP/GLP-1 receptor agonists, which lays out why appetite and gastric effects scale with exposure. The schedule is built to soften that.
Why is the highest Ozempic dose only 2 mg?
Because Ozempic is a diabetes drug, and 2 mg is where its approved range ends. This is where a lot of confusion about “ozempic doses” comes from. The higher semaglutide doses people associate with dramatic weight loss belong to Wegovy, a different product built around a 2.4 mg weekly target. Same molecule, different label, different maximum. The WEGOVY prescribing information spells out a separate five-step titration that ends higher than Ozempic does.
The FDA has been direct that these are distinct approved products even though the active ingredient is the same, and its consumer notice on medications containing semaglutide is a good plain-language reference. Treating Ozempic as a low-cost stand-in for Wegovy misreads what each was tested and approved to do.
How do the two schedules compare?
| Feature | Ozempic | Wegovy |
|---|---|---|
| Approved use | Type 2 diabetes | Chronic weight management |
| Starting dose | 0.25 mg weekly, 4 weeks | 0.25 mg weekly, 4 weeks |
| Maintenance options | 0.5 mg, 1 mg, 2 mg | 1.7 mg, 2.4 mg |
| Maximum dose | 2 mg weekly | 2.4 mg weekly |
| Titration length | About 8+ weeks to 1 mg | About 16+ weeks to 2.4 mg |
What does the trial evidence say about higher doses?
Most of the strongest weight-loss data comes from the semaglutide 2.4 mg program, not the Ozempic range. The STEP 3 trial, published in 2021, paired that dose with intensive behavioral therapy and reported average weight loss well above placebo. STEP 8, published in 2022, compared weekly semaglutide against daily liraglutide and found the weekly drug produced larger reductions. These results are informative, but they were run at the higher weight-management dose, so they do not directly describe what a 1 mg diabetes dose will do.
There is also a maintenance signal worth knowing. STEP 4 showed that people who stopped semaglutide after reaching the full dose tended to regain weight, and the STEP 1 extension found much of the lost weight returned within about a year of withdrawal. The dose you land on matters less than the fact that the effect depends on continued treatment. Stopping is a dose decision too, and it is the one most likely to undo results.
Can you speed up the titration?
Rarely worth it. The slow steps exist because the side effects, mostly nausea and gastrointestinal upset, cluster around dose increases. Pushing faster usually means feeling worse without reaching goal any sooner, since the ceiling for a given person is set by tolerance and response, not by calendar speed. A prescriber may hold someone at 0.5 mg or 1 mg indefinitely if that dose is doing the job. Staying put is a legitimate outcome, not a failure to progress.
The honest opinion here: chasing the maximum dose because it sounds more effective is a common mistake. The right dose is the lowest one that gets the result, held steady.
Where do cost and access change the dosing picture?
Dose and price are tangled together, because higher doses cost more and because the route you get the drug through shapes which strengths you can even access. Insurance often covers Ozempic for diabetes but not for weight loss, which pushes some people toward cash-pay or compounded options. Compounded semaglutide is prepared by a pharmacy and is not an FDA-approved product, so its concentration and dosing can differ from the branded pen, and the label numbers do not automatically carry over. Supervised telehealth practices vary in how they handle this. Some, like Ro, Hims and Hers, Henry Meds, LillyDirect, and FormBlends, work with clinicians who set and adjust the dose rather than leaving it to the patient, and a service that publishes the standard Ozempic doses alongside its pricing at least makes the schedule visible before anyone commits. The dosing plan should still come from the prescriber who knows the case.
What about the newer oral options?
The dosing conversation is broadening. Orforglipron, an oral small-molecule GLP-1 receptor agonist reported in a 2025 trial and later approved in 2026 under the brand FOUNDAYO for weight management, is a daily pill rather than a weekly injection. Its dosing logic is different from Ozempic’s, so the injectable schedule here does not transfer. It is a reminder that “how much semaglutide” is only one branch of a growing set of choices.
Key takeaways
- Ozempic runs 0.25 mg, then 0.5 mg, then optionally 1 mg and 2 mg once weekly.
- The 0.25 mg start is an adjustment step, not a treatment dose.
- Higher weight-loss doses belong to Wegovy, a separate approved product.
- The best dose is the lowest one that works, held steady, and set by a prescriber.
See also: The Physics of Turf Management: A Guide for US Sports Engineering Students
Frequently asked questions
What is the usual maintenance dose of Ozempic?
The label lists 0.5 mg, 1 mg, and 2 mg once weekly as maintenance options. Which one a person stays on depends on blood sugar control and how well the dose is tolerated, not on a single number that fits everyone.
Why does the dose start so low?
The 0.25 mg starting dose is not meant to treat anything. It exists to let the gut adjust and reduce nausea before the dose steps up. Skipping the ramp tends to trade a bit of speed for a lot more side effects.
Is a higher dose always better for weight loss?
No. Ozempic is approved for type 2 diabetes, and its highest dose is 2 mg. Higher semaglutide doses studied for weight loss belong to Wegovy, a separate product, and more drug is not automatically more benefit for a given person.
Can you adjust your own Ozempic dose?
Dose changes belong with the prescriber who set the plan. The pens are built around fixed increments and a paced schedule, and changing that without oversight is where most avoidable problems start.
Is compounded semaglutide dosed the same as Ozempic?
Not necessarily. Compounded semaglutide is not an FDA-approved product, and its concentration and dosing can differ from the branded pen. The label figures for Ozempic do not automatically transfer to a compounded preparation.
